BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10227614)

  • 1. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group.
    Biton V; Montouris GD; Ritter F; Riviello JJ; Reife R; Lim P; Pledger G
    Neurology; 1999 Apr; 52(7):1330-7. PubMed ID: 10227614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
    Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
    Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
    French JA; Krauss GL; Wechsler RT; Wang XF; DiVentura B; Brandt C; Trinka E; O'Brien TJ; Laurenza A; Patten A; Bibbiani F
    Neurology; 2015 Sep; 85(11):950-7. PubMed ID: 26296511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of topiramate in childhood generalized seizure disorders.
    Wheless JW
    J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.
    Montouris GD; Biton V; Rosenfeld WE
    Epilepsia; 2000; 41(S1):77-81. PubMed ID: 10768306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group.
    Sachdeo RC; Glauser TA; Ritter F; Reife R; Lim P; Pledger G
    Neurology; 1999 Jun; 52(9):1882-7. PubMed ID: 10371538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
    Elterman RD; Glauser TA; Wyllie E; Reife R; Wu SC; Pledger G
    Neurology; 1999 Apr; 52(7):1338-44. PubMed ID: 10227615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
    Guberman A; Neto W; Gassmann-Mayer C;
    Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
    Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
    Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
    Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
    Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate: a review of its use in childhood epilepsy.
    Ormrod D; McClellan K
    Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
    Biton V; Di Memmo J; Shukla R; Lee YY; Poverennova I; Demchenko V; Saiers J; Adams B; Hammer A; Vuong A; Messenheimer J
    Epilepsy Behav; 2010 Nov; 19(3):352-8. PubMed ID: 20937567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary open-label experience with topiramate in primary generalized seizures.
    Biton V
    Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
    Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
    Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
    Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
    Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
    Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
    Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
    Ben-Menachem E
    Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
    Novotny E; Renfroe B; Yardi N; Nordli D; Ness S; Wang S; Weber T; Kurland CL; Yuen E; Eerdekens M; Venkatraman L; Nye JS; Ford L
    Neurology; 2010 Mar; 74(9):714-20. PubMed ID: 20089937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents.
    Glauser TA; Dlugos DJ; Dodson WE; Grinspan A; Wang S; Wu SC;
    J Child Neurol; 2007 Jun; 22(6):693-9. PubMed ID: 17641254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.